Tag: Cancer: Skin
Nivolumab + Ipilimumab Tops Ipilimumab Alone in Metastatic Melanoma
Significant improvement seen in progression-free survival for combination of nivolumab and ipilimumab
Percentage of Women Mohs Fellows, Program Directors Has Increased
Significant positive trend seen between percentage of female representation and year since 1996
Reinforced Learning Model Can Improve Sensitivity of Skin Cancer Diagnosis
Correct diagnoses made by dermatologists increased with reinforcement learning, incorporating human preferences into AI model
Melanoma Presentation, Mortality Varies by Race
Black patients face higher mortality with melanoma independent of insurance status and severity at diagnosis
Lower Extremities Have Highest Surgical Site Infection Rates With Mohs Surgery
Findings especially for flap and graft closures
Microdosed Incisional Clindamycin Cuts SSI After Skin Cancer Surgery
Significantly fewer lesions receiving microdosed clindamycin, flucloxacillin required postoperative systemic antibiotics
New Model Helps ID Melanoma Patients With Lymph Node Involvement
Patient-centered methodology-generated probabilities better identify patients eligible for sentinel lymph node biopsy than those generated by conventional logistic regression analysis
Anti-PD-1 More Effective With Normal Vitamin D Levels in Melanoma
Significantly higher response rate and longer progression-free survival seen for patients with normal vitamin D
USPSTF: Evidence Lacking for Screening Asymptomatic Patients for Skin Cancer
Current evidence is insufficient for assessing balance of benefits and harms of screening asymptomatic adults, adolescents
AACR: mRNA-4157 Plus Pembrolizumab Beneficial in Melanoma
Combination of mRNA vaccine and pembrolizumab significantly prolongs recurrence-free survival versus pembrolizumab alone
